FHL3 and gastric cancer: Then, 120 samples showed higher level of FHL3, leading to lower differentiation (P = 0.009, Table 1), metastasis trend (P = 0.002, Table 1) and worse stage of TNM (P = 0.039, Table 1) in GC.